PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

bobbysee, page-9

  1. 77 Posts.
    lightbulb Created with Sketch. 30
    ahbbut mr mozzarc, words do not pay the bills
    and a quick look at the timeframe for a peer review to be done is something like 9 months conservatively, so if your waiting on 008 data to be reviewed we are march 2024 at earliest.
    tangible actions may come one day but massive dilution will come before that
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.